These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12036358)

  • 1. Conformations and receptor activity of desmopressin analogues, which contain gamma-turn mimetics or a psi[CH(2)O] isostere.
    Hedenström M; Yuan Z; Brickmann K; Carlsson J; Ekholm K; Johansson B; Kreutz E; Nilsson A; Sethson I; Kihlberg J
    J Med Chem; 2002 Jun; 45(12):2501-11. PubMed ID: 12036358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent antidiuretic agonists, deamino-vasopressin and desmopressin, and their inverso analogs: NMR structure and interactions with micellar and liposomic models of cell membrane.
    Lubecka EA; Sikorska E; Sobolewski D; Prahl A; Slaninová J; Ciarkowski J
    Biopolymers; 2016 May; 106(3):245-59. PubMed ID: 26916937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformation of desmopressin, an analogue of the peptide hormone vasopressin, in aqueous solution as determined by NMR spectroscopy.
    Walse B; Kihlberg J; Drakenberg T
    Eur J Biochem; 1998 Mar; 252(3):428-40. PubMed ID: 9546658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Potent, Selective, and Short-Acting Peptidic V
    Wiśniewski K; Qi S; Kraus J; Ly B; Srinivasan K; Tariga H; Croston G; La E; Wiśniewska H; Ortiz C; Laporte R; Rivière PJ; Neyer G; Hargrove DM; Schteingart CD
    J Med Chem; 2019 May; 62(10):4991-5005. PubMed ID: 31022340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-O-alkyltyrosine derivatives of 1-deamino-arginine-vasopressin: highly specific and potent antidiuretic agonists.
    Lammek B; Bankowski K; Misicka A; Manning M; Seto J; Sawyer WH
    J Med Chem; 1989 Jan; 32(1):244-7. PubMed ID: 2909737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and pharmacological evaluation of an analogue of the peptide hormone oxytocin that contains a mimetic of an inverse gamma-turn.
    Yuan Z; Blomberg D; Sethson I; Brickmann K; Ekholm K; Johansson B; Nilsson A; Kihlberg J
    J Med Chem; 2002 Jun; 45(12):2512-9. PubMed ID: 12036359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of trifluoroethanol on the solution structure and flexibility of desmopressin: a two-dimensional NMR study.
    Wang J; Hodges RS; Sykes BD
    Int J Pept Protein Res; 1995 May; 45(5):471-81. PubMed ID: 7591487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.
    Cheng LL; Stoev S; Manning M; Derick S; Pena A; Mimoun MB; Guillon G
    J Med Chem; 2004 Apr; 47(9):2375-88. PubMed ID: 15084136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective V₂-Agonist of Vasopressin Desmopressin Stimulates Activity of Serum Hyaluronidase.
    Dzgoev SG
    Bull Exp Biol Med; 2015 Aug; 159(4):424-6. PubMed ID: 26388582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective synthesis of Psi[CH(2)O] pseudodipeptides and conformational analysis of a PhePsi[CH(2)O]Ala containing analogue of the drug desmopressin.
    Hedenström M; Holm L; Yuan Z; Emtenäs H; Kihlberg J
    Bioorg Med Chem Lett; 2002 Mar; 12(6):841-4. PubMed ID: 11958975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylated peptide hormones: pharmacological properties and conformational studies of analogues of [1-desamino,8-D-arginine]vasopressin.
    Kihlberg J; Ahman J; Walse B; Drakenberg T; Nilsson A; Söderberg-ahlm C; Bengtsson B; Olsson H
    J Med Chem; 1995 Jan; 38(1):161-9. PubMed ID: 7837227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. V2-receptor-mediated relaxation of human renal arteries in response to desmopressin.
    Medina P; Segarra G; Vila JM; Chuan P; Domenech C; Lluch S
    Am J Hypertens; 1999 Feb; 12(2 Pt 1):188-93. PubMed ID: 10090347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antidiuretic reaction of the human and rat kidney to peroral administration of arginine-vasopressin and desmopressin].
    Natochin IuV; Grigor'ev AI; Buravkova LB; Larina IM; Prutskova NP; Shakhmatova EI
    Ross Fiziol Zh Im I M Sechenova; 2003 Feb; 89(2):184-92. PubMed ID: 12710188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anomalous antidiuretic activity of antidiuretic hormone antagonists.
    Kinter LB; Caltabiano S; Huffman WF
    Biochem Pharmacol; 1993 May; 45(9):1731-7. PubMed ID: 8494530
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis and some pharmacological properties of deamino(4-threonine,8-D-arginine)vasopressin and deamino(8-D-arginine)vasopressin, highly potent and specific antidiuretic peptides, and (8-D-arginine)vasopressin and deamino-arginine-vasopressin.
    Manning M; Balaspiri L; Moehring J; Haldar J; Sawyer WH
    J Med Chem; 1976 Jun; 19(6):842-5. PubMed ID: 950656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imidafenacin exerts the antidiuretic effect by enhancing vasopressin-related responses in orally water-loaded rats.
    Yamazaki T; Fukata A; Muraki Y
    Eur J Pharmacol; 2016 Nov; 791():72-77. PubMed ID: 27568834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of antidiuretic hormone in cold-induced diuresis in the anaesthetized rat.
    Broman M; Källskog O; Nygren K; Wolgast M
    Acta Physiol Scand; 1998 Apr; 162(4):475-80. PubMed ID: 9597114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential binding of desmopressin and vasopressin to neurophysin-II.
    Wang J; Breslow E; Sykes BD
    J Biol Chem; 1996 Dec; 271(49):31354-9. PubMed ID: 8940142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative analysis of 1-desamino-arginine-vasotocin, 1-desamino-1-monocarba-arginine-vasotocin and desmopressin antidiuretic effect in rats].
    Bogolepova AE; Zaĭtseva KV
    Ross Fiziol Zh Im I M Sechenova; 2008 Oct; 94(10):1191-4. PubMed ID: 19065832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.
    Manning M; Stoev S; Chini B; Durroux T; Mouillac B; Guillon G
    Prog Brain Res; 2008; 170():473-512. PubMed ID: 18655903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.